Palliare, a leading developer of advanced insufflation technologies, has received EU CE Mark certification under the new EU Medical Devices Regulation (MDR) for its EVA15 insufflator and smoke evacuation system. This makes it one of the first laparoscopic and endoscopic…
bspr Inc. (Shibuya-ku, Tokyo, CEO: Yosuke Toyama), in collaboration with BHQ Corp. (Saitama City, Saitama Prefecture, CEO: Masahito Kawamori), is pleased to announce the release of the beta version of the smartphone app “Braincure” that utilizes the internationally standardized brain…
Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, received written notification from NYSE American LLC (“NYSE American” or the “Exchange”) stating that the staff of NYSE…
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced the completion of enrollment to the randomized, double-blind phase III ALTAIR clinical trial (JapicCTI-205363/NCT04457297). ALTAIR is the circulating tumor DNA (ctDNA)-guided treatment escalation arm of the CIRCULATE-Japan adaptive…
Tivic Health® Systems, Inc. (“Tivic”, Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today issued the following letter from the CEO, Jennifer Ernst, providing additional information regarding the company’s current report on Form 8-K filed with the…
The global adult vaccine market is expected to witness substantial growth, reaching a projected value of US$ 27.65 Billion by 2028, with a strong compound annual growth rate (CAGR) of 6.01% during 2022-2028. Vaccines play a crucial role in global…
Shapeways, Inc. (NYSE: SHPW), a global leader in the digital manufacturing industry, announced today the expansion of its medical customer base within its Enterprise Manufacturing Solutions business by securing two significant contracts. These strategic partnerships should generate revenue of approximately $2.5…
Impetus Grants, a nonprofit foundation dedicated to funding aging-related research that might otherwise be overlooked by traditional funding sources, announces a new round of matching funding. Hevolution Foundation, a global non-profit organization that provides grants and early-stage investments to incentivize research…
Anova Enterprises, Inc. (Anova), an organization dedicated to accelerating the development of promising treatments to market announced the FDA authorization of a Phase II clinical trial to re-assess a targeted treatment in light of newly discovered pharmacogenomic predictor data in…
ViroCell Biologics (“ViroCell” or the “Company”), a specialist Contract Development and Manufacturing Organisation (“CDMO”) in cell and gene therapy clinical trials, announces the appointment of Brian Collins as Chief Financial Officer (“CFO”). Brian brings a wealth of relevant experience to…
UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today announced the appointment of James Robinson, former President and Chief Executive Officer (CEO) of Urovant Sciences, to its…
Oak Street Health, a network of value-based primary care centers for adults on Medicare and the only primary care provider to carry the AARP name, is now welcoming patients at the new Midtown center at 1310 Broadway in Gary, IN. This is the…